London: Mobile health (mHealth) applications have emerged as powerful tools in transforming healthcare delivery and empowering individuals to take charge of their well-being. These apps, when regulated effectively, not only enhance patient outcomes but also contribute significantly to the efficiency and accessibility of healthcare services. With the increasing adoption of mHealth apps, regulatory frameworks play a crucial role in ensuring their safety, effectiveness, and adherence to ethical standards, states GlobalData, a data and analytics company.
Regulated mHealth apps, overseen by regulatory bodies such as the Food and Drug Administration (FDA) in the US, undergo rigorous scrutiny to meet stringent quality and safety standards. These standards encompass various aspects, including data privacy, clinical validation, interoperability, and user experience, to ensure that patients and healthcare providers can rely on these apps with confidence.
“One of the key advantages of regulated mHealth apps is their ability to improve access to healthcare services, especially in underserved or remote areas. mHealth apps enable patients to monitor their health, access medical information, consult healthcare professionals remotely, and even receive timely reminders for medication and appointments. This not only reduces the burden on traditional healthcare facilities but also empowers patients to actively participate in their healthcare journey,” said Alexandra Murdoch, Senior Medical Analyst, Global Data.
In the realm of chronic disease management, regulated mHealth apps play a pivotal role in facilitating continuous monitoring and support for patients. For instance, apps designed for diabetes management can track blood glucose levels, monitor dietary habits, provide medication reminders, and offer insights based on real-time data analysis. Similarly, apps focusing on mental health offer tools for mood tracking, relaxation techniques, therapy sessions, and crisis intervention, enhancing the overall mental well-being of users.
According to GlobalData’s Thematic Intelligence report, “Regulated mHealth Apps,” forecasts the regulated mHealth app market value to reach $15.6 billion in 2033. The market has been growing since 2015, but thanks to COVID-19, mHealth apps were adopted rapidly and started to be used on a regular basis in healthcare.
The use of digital health devices, including mHealth apps, has not slowed with the end of the COVID-19 pandemic. With that in mind, regulatory oversight of mHealth apps is important, as it ensures data security and privacy, addressing concerns related to the collection, storage and sharing of health information.
“As the demand for digital healthcare solutions continues to rise, the importance of regulatory oversight cannot be overstated. Regulated mHealth apps undergo continuous monitoring, updates, and evaluations to ensure ongoing compliance with evolving standards and best practices,” Murdoch concluded.
